I still remember the evening I applied for that IPO. The grey market premium was screaming 80%. My broker group on WhatsApp was buzzing. Three friends had already applied. I didn’t read a single page of the prospectus. I just opened my demat app, entered the lot size, and hit submit — fully convinced I was about to make easy money.
The stock listed at a 12% discount on day one. I held it for six months hoping it would recover. It didn’t. I finally exited at a 23% loss.
That was my tuition fee. And honestly? It was worth it — because it forced me to learn how to analyse IPO before investing instead of chasing hype. If you’re reading this before making that kind of mistake, good. Let’s make sure you don’t pay the same fees I did.
What Most People Actually Do (And Why It Usually Goes Wrong)
Here’s the uncomfortable truth. Most retail investors in India don’t analyse an IPO at all. They apply based on three things: a high GMP (grey market premium), a popular brand name, or peer pressure. And in bull markets, this sometimes works — which makes it even more dangerous, because it reinforces the wrong lesson.
In FY25, India saw 80 mainboard IPOs raising over ₹1.63 lakh crore in total — a massive jump from ₹61,900 crore in FY24. [web:4] The sheer volume created a lottery-ticket mentality. Apply to everything. Hope for listing gains. Sell on day one. But in 2025 and early 2026, that illusion cracked. Retail investors began skipping IPOs because too many were listing flat or below issue price. [web:7] The party wasn’t stopping — it was just getting more selective.
And that’s exactly the point. When you learn how to analyse IPO before investing, you stop playing a guessing game and start making calculated decisions. You don’t need to apply to every IPO. You just need to get the right ones right.
Start Here: The DRHP Is Your Best Friend (If You Know What to Look For)
The Draft Red Herring Prospectus (DRHP) is the document every company must file with SEBI before going public. It’s public. It’s free. And almost nobody reads it. That’s your edge.
I know — it’s 400 pages of legal language and financial tables. You don’t need to read all of it. But there are four specific sections that tell you almost everything you need to know about whether an IPO deserves your money.
- Objects of the Issue — What is the company planning to do with the money raised? If 60–70% of IPO proceeds are going towards an “Offer for Sale” (OFS), that means existing investors are cashing out, not the company raising capital for growth. Be very careful here.
- Promoter Background and Shareholding — Who are the people running this company? What’s their track record? Are they reducing their stake significantly post-IPO? High promoter dilution can be a red flag.
- Risk Factors Section — Companies are legally required to disclose what can go wrong. Read the first 10 risk factors seriously. If they list regulatory risks, litigation, or revenue concentration from a single client, that matters.
- Financial Statements (Last 3 Years) — Revenue growth, profit trends, debt levels. This is the heartbeat of the business. If the company has been growing revenue at 30% CAGR but profits are shrinking, you need to understand why before you apply.
Think of the DRHP like the bio someone writes on a dating app. It’s curated, yes. But if you read between the lines, it still tells you a lot. The IPO analysis process starts and ends with this document.
The Five Things I Now Check Before Every IPO Application
Over the years, I’ve built a personal checklist that I run through before every single IPO. Not because I enjoy homework — but because I’ve lost money enough times to know that skipping it is expensive.
1. Business Model Clarity
Can you explain what this company does in two sentences? If you can’t, that’s a problem — not a sign you should research harder, but a sign the business itself might be complex, niche, or hard to evaluate. The best IPO investments I’ve made were in companies whose business models I could understand immediately: strong brands, clear revenue streams, obvious market demand.
Ask yourself: Is this company solving a real problem? Does it have a moat — something that makes it hard for competitors to eat its lunch in the next five years?
2. Financial Health: The Numbers That Actually Matter
When you learn to analyse an IPO properly, financial ratios become your compass. Here’s what to look at:
| Metric | What It Tells You | Healthy Benchmark (General) |
|---|---|---|
| Revenue Growth (3Y CAGR) | Is the business actually expanding? | >15% for growth sectors |
| EBITDA Margin | Operating profitability before tax/interest | Positive and improving |
| Debt-to-Equity Ratio | Financial risk and leverage | Below 1.5x preferred |
| Return on Equity (ROE) | How efficiently is shareholder money used? | >15% is a good sign |
| P/E vs. Industry Peers | Is the IPO price reasonable or overvalued? | Compare to listed competitors |
| Cash Flow from Operations | Is profit real or accounting-driven? | Should be positive and consistent |
The ratio I almost always start with is the Price-to-Earnings (P/E) comparison. Find 2–3 listed competitors in the same sector on NSE or BSE. What P/E are they trading at? Now look at the IPO’s implied P/E based on the issue price. If the IPO is priced at a 40–50% premium to industry peers without a clear justification — high growth, unique moat, dominant market share — that’s a valuation red flag.
3. Promoter Credibility and Institutional Interest
I’ll be honest — this is the factor I underweighted early in my investing journey. I focused entirely on numbers and ignored the people. That was a mistake.
A company’s promoters matter enormously. Check their past businesses. Have they run listed companies before? What was the outcome? Are any of them involved in legal proceedings (the DRHP will disclose this)? Also look at whether marquee institutional investors — category-I AIFs, established PE funds — have taken pre-IPO stakes. That’s not a guarantee of success, but it does mean sophisticated money has reviewed the business.
4. IPO Structure: Fresh Issue vs. OFS
This one is critical, and most retail investors completely ignore it. When a company comes out with an IPO, the money can go in two directions. A fresh issue means the company gets the money — to expand, repay debt, fund working capital. An Offer for Sale (OFS) means existing shareholders are selling their shares to the public. The company gets nothing.
OFS-heavy IPOs aren’t automatically bad. But ask yourself: why are the early investors rushing to exit right now? Are they cashing out at peak valuation? The DRHP must disclose this clearly, and understanding it is fundamental to any IPO analysis.
5. Valuation vs. Sector Growth Story
Even a great company at the wrong price is a bad investment. This is where how to analyse IPO before investing gets nuanced. Look at the sector trajectory. Is the industry growing? Where is it in its cycle? A company in a structurally declining sector can show great past numbers but terrible future prospects. Conversely, a company in an emerging sector — EV infrastructure, specialty chemicals, digital financial services — might justify a premium valuation if the growth runway is genuinely long.
Use the IPO’s own industry report (included in the DRHP) but cross-check it with independent sources. Companies always paint the rosiest picture of their sector in that report. That’s just how it works.
Myth-Busting: Two Things the IPO Crowd Gets Completely Wrong
Myth #1: High Grey Market Premium (GMP) Means the IPO Will List Big
The grey market. Everyone checks it. I used to check it obsessively. But here’s what I’ve learned after watching it for years: GMP is increasingly unreliable and easily manipulated. In 2024–25, multiple IPOs with strong GMPs listed flat or in the red. [web:11] The grey market is an unofficial, unregulated space. Operators can inflate GMP deliberately to generate FOMO among retail investors. By the time you see a 70–80% GMP and feel the excitement, sophisticated institutional money has already made its decision — and it might not match the hype.
Use GMP as a very rough sentiment indicator at best. Never use it as a primary reason to apply. If you do, you’re essentially gambling on what other gamblers are guessing. That’s not IPO analysis. That’s noise.
Myth #2: If It’s Oversubscribed 100x, It Must Be a Great Company
Subscription numbers feel like social proof. “100x subscribed” sounds impressive. Surely 100x more smart people can’t be wrong, right? Wrong. High subscription, especially in the retail and NII (Non-Institutional Investor) categories, often reflects listing-gain speculation rather than fundamental conviction.
In FY25, the average retail oversubscription across mainboard IPOs was 35x, and QIB oversubscription averaged 102x. [web:4] But many highly subscribed IPOs still underperformed post-listing. Subscription tells you about demand for the allotment lottery — not about the quality of the business. True IPO analysis means forming your own view before looking at what the crowd is doing. Not after.
The GMP Trap, The Hype Cycle, and What Smart Money Actually Watches
Let me tell you about a different kind of investor I met at a Nifty options meetup in Delhi a couple of years ago. He had been applying to IPOs for over a decade. His hit rate was remarkable — not because he had better data, but because he had a completely different question he asked first.
Most people ask: “Will this IPO list at a gain?” He asked: “Would I want to hold this stock for three years if it listed flat?” That one shift in framing changes everything about how you analyse an IPO before investing.
If your honest answer is “no, I’d only want this for a listing pop,” then at least you’re being honest with yourself. Apply with that risk in mind, keep it to a small allocation, and don’t anchor to the issue price. But if your honest answer is “yes, this is a business I believe in at this price,” then you’ve found something worth being more aggressive about.
Smart institutional money — the QIBs who were 102x subscribed on average in FY25 — doesn’t just chase listing gains. [web:4] They’re anchoring to long-term value. Following their cues (by checking anchor investor lists in the DRHP) gives you a signal, though not a guarantee.
Tools like Goela AI are also emerging to help retail investors screen and analyse IPO fundamentals more systematically — bridging the gap between raw DRHP data and actionable insight. Worth exploring if you want to speed up your research process without compromising quality.
What Retail Investors Are Getting Right in 2026 — And What’s Still Missing
Here’s something that actually gives me hope. By April 2026, retail investors have started avoiding obviously weak IPOs. In the first few months of 2026, the retail portions of 10 out of 18 IPOs launched were under-subscribed. [web:7] And guess what? Many of those stocks are now trading below issue price. The crowd was right to stay away.
That’s maturity. That’s the market learning. But the gap that still exists is the step between “avoid bad IPOs” and “confidently identify good ones.” Most retail investors know what to reject. They don’t yet have a reliable framework to say yes with conviction. That’s what a proper IPO analysis process gives you.
And it’s not as complicated as it sounds. The whole thing boils down to four honest questions: Is this a good business? Is it priced fairly? Are the promoters trustworthy? And will the money raised actually build something — or just reward those who came before me?
Your Practical Action Steps Before the Next IPO
Enough theory. Here’s exactly what to do the next time an IPO opens for subscription and you’re wondering whether to apply.
- Download and skim the DRHP within 30 minutes. You don’t need to read it all. Focus on: Objects of the Issue, the last 3 years of financial statements, the risk factors section, and the promoter details. These four sections answer 80% of the questions that matter. The DRHP is publicly available on SEBI’s website and the exchange filings — free, no subscription required. This single habit separates serious investors from lottery players when it comes to how to analyse IPO before investing.
- Run a quick valuation sanity check. Find 2 listed peers on NSE or BSE. Calculate their current P/E and P/B ratios. Now compute the implied P/E of the IPO at its upper price band using the latest EPS from the DRHP. Is the IPO priced at a premium, discount, or at par? If it’s a significant premium, write down exactly why the company deserves it. If you can’t articulate a clear reason, that’s your answer — and it’s a no until you can.
- Ask the holding question before applying. Before you submit your application, answer this out loud: “If this stock lists flat or at a 10% discount and stays there for 12 months, would I still be comfortable holding it?” Your gut answer to that question — honest, unfiltered — is often the best IPO analysis you’ll ever do. It forces you to separate conviction from FOMO, and that one distinction will save you more money than any financial ratio ever will.
Frequently Asked Questions
What is the most important factor to check when you analyse an IPO before investing?
The single most important factor is the use of IPO proceeds combined with the company’s financial track record. If the majority of the issue is an Offer for Sale (OFS) — meaning existing investors are exiting rather than the company raising fresh capital — treat it as a yellow flag. Combine this with at least three years of revenue and profitability data, and you have the foundation of any solid IPO analysis. Everything else builds on top of this.
Is GMP (Grey Market Premium) a reliable indicator for IPO listing gains?
No — and this is a myth worth repeating. GMP is an unofficial, unregulated market. In 2024–25, multiple high-GMP IPOs in India listed flat or at a discount. [web:11] Operators can and do inflate GMP to create retail investor FOMO. Use GMP as a very loose sentiment gauge if at all, but never base your application decision on it. Your IPO analysis should rest on fundamentals, not grey market gossip.
How do I know if an IPO is overvalued compared to its peers?
Compare the IPO’s Price-to-Earnings (P/E) ratio — calculated using the upper price band and the most recent EPS from the DRHP — against 2–3 listed competitors on NSE or BSE. [web:6] If the IPO commands a 40–50% premium over industry peers without a compelling growth justification, it’s likely overvalued. Also check the Price-to-Book (P/B) ratio for capital-intensive businesses like manufacturing or banking. Valuation is the most overlooked step in how to analyse IPO before investing, and it’s also the most punishing one to get wrong.
Should I always avoid IPOs that are mostly an Offer for Sale (OFS)?
Not necessarily. Some OFS-heavy IPOs are from strong, profitable companies where early investors are simply monetising after years of value creation — that’s legitimate. What you’re checking for is why they’re selling, how much of the company is being offloaded, and whether the promoters still retain a meaningful stake post-IPO. High promoter dilution combined with a weak business track record is the red flag. Strong promoter retention even in an OFS tells a very different story.
The Line That Changed How I Invest
Someone told me years ago: “The IPO market is the only market where the seller knows infinitely more than the buyer — and the seller chose this exact moment to sell.” That line changed everything. It didn’t make me cynical about IPOs. It made me disciplined. It reminded me that how to analyse IPO before investing isn’t just a skill — it’s a form of respect for your own money. Because on the other side of your application is a company, its bankers, and its early investors who have spent months deciding this is the right price to sell at.
The question is: do you know something they don’t? Or have you just done enough homework to agree — or disagree — with a clear head?
An IPO is not a lottery ticket. It’s a business ownership decision made under time pressure. Treat it like one.
